Original news and analysis on international IP policy
Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent challenge at the China State Intellectual Property Office today, asking for the invalidation of a Gilead patent on a hepatitis C medicine.
As the European Patent Office (EPO) prepares to welcome a new president, staff members and patent practitioners are setting out their priorities and suggestions for the newcomer, António Campinos. Topping the list for patent examiners is ending the contentious relationship between management and employees. Patent attorneys and litigators, meanwhile, want to see more attention paid to creating a fair balance between the speed of patent grants and patent quality.
«Доступ к генетическим ресурсам» и «справедливое и честное распределение выгод от их использования» были камнем предкновения на всех тринадцати Конференциях сторон-участников Соглашения Организации Объединенных Наций от 1993 года о Биологическом разнoобразии (CBD). Слова в кавычках составляют третью задачу договора, которая переплетена с двумя первыми, а именно с задачей консервации и устойчивого использования. По первым буквам английского названия эта задача сокращенно обозначается как «ABS». Несмотря на 25 лет усилий и при размерах био-экономики порядка 1 триллиона долларов [1], было заключено немного контрактов [2]. И в этом малом количестве контрактов денежная часть так незначительна, что их участники не пожелали ее обнародовать. «Закон ABS Бразилии» от 2015, который вошел в силу 6 ноября 2017, позволяет чтобы отчисления от суммы продаж составляли всего одну десятую процента[3]. Используя выражение известного ученого-законоведа, потребитель платит «пшик» авторам биоресурсов.
Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is one of two. An interview with Carlos Correa will follow.]
If the Federal Circuit will not correct its misplaced jurisprudence, then it is time for the Supreme Court to correct course, and bring into line the Federal Circuit’s IPR standing to appeal jurisprudence, with the Supreme Court’s (and other Circuits’) more forgiving law of allowing petitioners whose petitions are denied, to challenge such denials, particularly when Congress has set forth reasonable conditions, like Section 319, upon which such challenge is to occur, write Charles Macedo, Chandler Sturm, and James Howard.
A new PCT Proposal seeks to amend the PCT Regulations so as to provide Member States to enter into a voluntary or opt-in arrangement that would allow such Member state to ‘outsource’ it’s patenting mechanism to another country/ regional treaty office even if it is not a member of such regional treaty. However, a patenting office with a full-fledged examination cadre acts a core component in capacity building for the Member State and serves to protect against imposition of TRIPs plus provisions by being an active part of the national policy discourse. Instead of opting in for full-fledged ‘outsourcing’ of their patenting function, it may be a better idea (in the long term) to develop their internal patent office cadre, develop appropriate IP policies best suited to their stage of development and at the same time, giving deference to the patenting decisions of like-minded countries. Developing countries will stand to benefit more by showing deference to decisions of like countries, rather than delegating the power to make those decisions. By granting a Contracting state the power to grant and reject patents of another State, this proposal could tantamount to introducing substantive patent law provisions through the backdoor: an endeavour to harmonize substantive patent law that the WIPO has failed to achieve over the years.
The United States today released a list of products imported from China to the US on which additional tariffs will be placed as a measure aimed at pressuring China to change its practices the US says force US companies to give up intellectual property and transfer technology. Some industries have been dropped from the list such as pharmaceuticals, while a second list has now been announced, officials told reporters this morning.
The heads of the patent offices of China, Europe, Korea, Japan and the United States met today and declared artificial intelligence one of the top strategic priorities for them as a group. Other efforts included work on harmonising patent practices, the Global Dossier program, classification of new technologies, and patents and standards, according to a release.
The European Commission appointed 52 experts today to a new High-Level Expert Group on Artificial Intelligence, and also launched the AI Alliance, an online forum to facilitate broad participation in dialogue on the burgeoning technology.
Faced with a longstanding lack of progress at the World Trade Organization and the World Intellectual Property Organization on the protection of genetic resources and traditional knowledge, some developing countries are examining the possibility of moving outside the multilateral system toward a plurilateral agreement with like-minded countries. During an international conference last week, panellists pondered the prospects of such an option.